Heska Announces Amended Agreement Wit...( LOVELAND Colo. Dec. 28 /- Heska C...),Health

LOVELAND, Colo., Dec. 28 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) today announced its Des Moines-based subsidiary ("Heska Des Moines") has amended its bovine vaccine distribution agreement with Agri Laboratories, Ltd. ("AgriLabs"). Heska Corporation ("Heska" or the "Company") reports revenue generated under this agreement in Heska's Other Vaccines, Pharmaceuticals and Products segment. Under the terms of the amended agreement, Heska Des Moines agreed to fund a portion of development spending under the remaining research and development agreement with AgriLabs in return for certain distribution rights.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO )

Under the amendment, AgriLabs will continue to market the underlying bovine vaccines in the United States, Africa and Mexico through December 15, 2013. Subject to minimum purchase requirements, AgriLabs' rights in these regions will be exclusive through December 15, 2009. Heska Des Moines is free to sell these bovine vaccines to any party of its choosing in other regions of the world. AgriLabs will also maintain non-exclusive rights to these bovine vaccines in Canada through December 15, 2008.

"The vaccines underlying this agreement are well known in the United States and Africa cattle markets where they are sold under AgriLabs' label and tradenames Titanium(R) and MasterGuard(R). We were pleased when AgriLabs began to sell these vaccines in new markets, first in Africa and most recently in Mexico," said Robert Grieve, Heska's Chairman and CEO. "We are pleased to continue our positive working relationship with AgriLabs and continue to benefit from their lives
'/>"/>